MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Mamiya et al. conducted a systematic review to examine how productivity gain or loss is measured in health economic evaluations, aiming to identify the most widely used instruments and their properties.

On July 1, 2025, the revised EBM (German Uniform Evaluation Standard) catalog for the third quarter of 2025 came into force. The main changes introduced concern updates of the contents (services legends, preambles of several EBM subchapters) and the introduction of new EBM codes for the reimbursement of transmitters for telemonitoring and telemedical monitoring of implantable cardiac devices, as well as codes for the services provided within the co-funded study on low-dose pulsed ultrasound for pseudarthrosis.

MTRC is pleased to present the 2025 European MedTech Market Access Playbook - your annual, refresh‑and‑reuse roadmap to every EU reimbursement deadline.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Publications Digest. In a recent publication, Heeg et al. proposed a systematic framework to define biologically and clinically plausible survival extrapolations, addressing inconsistencies in current health technology assessments (HTA).

MTRC is pleased to announce the release of its latest White Paper: “Case study: Market Size Analysis for Mechanical Intracranial Thrombectomy in Europe”. The report highlights the role of procedure and diagnosis coding data in evaluating market size and demonstrates the methodologies of how the administrative databases from multiple European countries – the French CCAM, German OPS and Spanish CIE-10-ES – can be used to quantify real-world procedure volumes, characterize types of devices used and with that potential reimbursement pathways for the new technology.

Driven by the substantial productivity growth and increase in the size of the team, MTRC now offers a flexible, three-tier system - Start-up, Basic, and Comprehensive, for health economic models to medical device, in-vitro diagnostic, and digital technology companies. With competitive entry-level pricing of just €13,500 and €21,500, now is the perfect time to equip your team with an impactful health economic argument to power your market access and commercial success across Europe and globally.

Driven by the substantial productivity growth and increase in the size of the team, MTRC now offers a flexible, three-tier system - Start-up, Basic, and Comprehensive, for creating value dossiers tailored to medical devices, IVD tests, and digital technologies. With competitive entry-level pricing of just €12,500 and €19,500, now is the perfect time to equip your team with an impactful dossier to power your market access and commercial success across Europe and globally.

On June 30, 2025, NHS England released a draft summary of core changes between OPCS-4.10 and OPCS-4.11, a procedure coding classification updated every three years. Multiple changes are proposed, including 64 new three-character (category) codes and 568 new four-character (subcategory) codes. The final summary is scheduled for publication on November 1, 2025, with OPCS-4.11 set to take effect on April 1, 2026.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Sustainability Publications Digest. In a recent publication, Thöne et al. performed a comparative life-cycle assessment of single-use and reusable flexible ureterorenoscopes to quantify their greenhouse gas emissions and health impacts within a German hospital setting. The study demonstrated that reusable devices are associated with nearly four times fewer greenhouse gas emissions and lower Disability-Adjusted Life Years per intervention than single-use instruments. These findings underscore that medical device choices can have substantial environmental and health impacts, supporting a shift toward more sustainable healthcare solutions.

In the first and second quarters of 2025, the Dutch Healthcare Institute (ZIN) published three coverage positions concerning the ENT, gastrointestinal, and in-vitro diagnostic fields. Two of the three decisions (Internal nasal valve correction for airway blockage and molecular diagnostics of the NTRK gene fusion in cancer patients) received favorable recommendations for coverage under basic health insurance.

MTRC shares the most relevant and impactful publications in the field of market access and HEOR for medical technologies in Europe through its Health Economic Publications Digest. In a recent publication, Donovan et al. introduced Cost-IS, a tool designed to estimate the costs of implementing digital health solutions. Its development involved a modified e-Delphi process with 12 experts, who reached consensus on its core design and components. However, consensus was lacking regarding the required user knowledge, how specific the tool should be for digital health, and its digital availability. The authors concluded that further testing is needed to establish the tool’s feasibility in real-world settings.

In June 2025, the National Institute for Health and Care Excellence (NICE) published three new Interventional Procedures Guidance (TAVI in native aortic valve regurgitation, targeted muscle reinnervation for limb amputation pain, laparoscopic insertion of inactive implant for GERD). Furthermore, three clinical guidelines were updated.